Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer
Crossref DOI link: https://doi.org/10.1186/s12885-016-2260-y
Published Online: 2016-03-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mikah, Phillip
Krabbe, Laura-Maria
Eminaga, Okyaz
Herrmann, Edwin
Papavassilis, Philipp
Hinkelammert, Reemt
Semjonow, Axel
Schrader, Andres-Jan
Boegemann, Martin
License valid from 2016-03-14